BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3259612)

  • 1. Theophylline-resistant and theophylline-sensitive "active" and "total" E rosette-forming lymphocytes in patients with systemic scleroderma.
    Skopinska-Rózewska E; Majewski S; Błaszczyk M; Włodarska B; Jabłońska S
    J Invest Dermatol; 1988 Jun; 90(6):851-6. PubMed ID: 3259612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theophylline-resistant and theophylline-sensitive "early" and "late" E rosette-forming cells in young and aged humans.
    Malkowska-Zwierez W; Skopińska-Rózewska E; Wróblewski T; Kwarecka M; Pawińska M; Wlodarska B; Polakowski IJ; Pazdur J
    Mech Ageing Dev; 1987 Sep; 40(1):1-8. PubMed ID: 3501047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface antigens of theophylline-resistant and theophylline-sensitive human E rosette-forming T lymphocytes.
    Skopinska-Rózewska E; Ettenger RB; Plaeger-Marshall S; Sieniawska M; Fine RN
    Folia Biol (Praha); 1988; 34(1):58-62. PubMed ID: 2968929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of human mononuclear cell fractions separated on the basis of theophylline sensitivity of E rosette forming ability.
    Divakaran S; Wangel AG
    Immunobiology; 1983 Dec; 165(5):500-7. PubMed ID: 6229472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma from insulin-dependent diabetics inhibits theophylline sensitive T-lymphocytes demonstrated in E-rosette assay.
    Buschard K; Madsbad S; Rygaard J
    J Clin Lab Immunol; 1983 Jul; 11(3):123-8. PubMed ID: 6224937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of in vitro theophylline on T lymphocytes from patients with ulcers].
    Słotwiński R; Włodarska B; Muszyński J
    Pol Tyg Lek; 1990 Feb 19-26; 45(8-9):156-60. PubMed ID: 2216957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro sensitivity of T lymphocytes to theophylline in healthy adults and patients following cadaver kidney allotransplantation].
    Kaden J; Groth J; Eichler C; May G; Janisch W; Kaden K; Samietz C; Hansen C; Welsch C
    Z Urol Nephrol; 1986 Nov; 79(11):671-7. PubMed ID: 3551388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal values and membrane markers of theophylline-sensitive and theophylline-resistant human T-lymphocytes.
    Kaden J; Samietz C; Kaden K; Groth J; Grunow R; Volk HD
    Allerg Immunol (Leipz); 1986; 32(1):27-32. PubMed ID: 2940848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of theophylline on the proportion and function of T-suppressor cells in asthmatic children.
    Lahat N; Nir E; Horenstien L; Colin AA
    Allergy; 1985 Aug; 40(6):453-7. PubMed ID: 2932032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active rosette forming cells as a possible functional subpopulation of human peripheral T lymphocytes.
    Harada M; Ishino C; Mori T; Hattori K
    Jpn J Exp Med; 1977 Dec; 47(6):489-94. PubMed ID: 305494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous "in vitro" variations of theophylline sensitivity in human peripheral blood lymphocytes.
    Ciboddo GF; Gromo G; Barbieri MC; Crosti F; Ferrero ME; Besana C; Rugarli C
    Boll Ist Sieroter Milan; 1983 May; 62(2):190-4. PubMed ID: 6313016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies of the role of cellular immunity and angiogenetic changes in the pathogenesis of circumscribed scleroderma].
    Majewski S; Błaszczyk M; Chibowska M; Rosińska-Borkowska D; Kencka D; Rudnicka L; Marczak M; Makieła B; Skiendzielewska A; Jabłońska S
    Przegl Dermatol; 1990; 77(4):249-51. PubMed ID: 2267352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theophylline-sensitive and theophylline-resistant E-rosette-forming cells in leprosy.
    Dang DT; Pham MH; Hoang TL; Nguyen HH; Phan LT; Wright EP
    Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):251-3. PubMed ID: 6609894
    [No Abstract]   [Full Text] [Related]  

  • 14. Theophylline modulation of E-rosette formation: an indicator of T-cell maturation.
    Limatibul S; Shore A; Dosch HM; Gelfand EW
    Clin Exp Immunol; 1978 Sep; 33(3):503-13. PubMed ID: 310744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous rosette-forming T cells and their relationship to OKT4+ and OKT8+ cells in chronic HBV infection.
    Victorino RM; Lucas M; de Moura MC
    J Clin Lab Immunol; 1986 Jul; 20(3):137-41. PubMed ID: 2943900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the population of active rosette-forming cells: a sensitive index for mortality among thermal injury patients.
    Singh H; Herndon DN; Stein MD
    Burns Incl Therm Inj; 1988 Apr; 14(2):85-90. PubMed ID: 3390739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological status of patients in carcinoma head and neck.
    Vasenwala SM; Aziz M; Rattan A; Ahmad KN
    Indian J Cancer; 1989 Sep; 26(3):137-44. PubMed ID: 2630426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Selected cellular immunity parameters in patients with Lesniowski-Crohn disease].
    Słotwiński R; Szczygieł B; Lech G; Kolewska D; Wasik M
    Pol Merkur Lekarski; 1997 Nov; 3(17):224-7. PubMed ID: 9523477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of human tumor antigens on the active E-rosette-forming test (ARFT): a new diagnostic method for cancer.
    Wang K
    Clin Immunol Immunopathol; 1984 Oct; 33(1):1-12. PubMed ID: 6332697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous rosette forming cells in subjects at risk for the acquired immunodeficiency syndrome.
    Cabral CM; Sen L; Palacios MF; Muchinik G; Maero EB; Scaglione C; Estevez ME
    AIDS Res; 1986; 2(4):335-42. PubMed ID: 3814262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.